What happened
Anduril Industries has secured a position on a new multi-vendor U.S. Space Force contract vehicle with a ceiling of $1.8 billion, a development that further cements its status as a key technology provider to the Pentagon. This award adds another major government program to the defense technology firm’s rapidly growing backlog.
The contract win continues a pattern of Anduril securing large-scale, competitive government programs. The company was previously selected as one of two finalists for the Air Force’s an autonomous fighter drone program, known as Collaborative Combat Aircraft (CCA) [1]. It has also won significant contracts with other branches of the armed forces, including a 10-year, $642 million counter-drone award from the Marine Corps and a $99.7 million deal to integrate its Lattice AI software into the Space Surveillance Network [1]. Furthermore, Anduril assumed control of the Army’s $22 billion Integrated Visual Augmentation System (IVAS) augmented-reality headset program from Microsoft in 2025 [1].
How the market reacted
The prediction market for Anduril’s initial public offering did not show a distinct, time-aligned reaction to the contract announcement. The Kalshi contract tracking whether Anduril will IPO by the end of Q1 2026 (KXIPOANDURIL-26MAR01) registered no price change following the news.
This lack of movement comes amid conflicting signals between private market enthusiasm and public market timing speculation. In private secondary markets, investor demand for Anduril shares reportedly outstrips supply by a ratio of 2.6-to-1 [6]. Share prices on these platforms have recently implied valuations ranging from a $60 billion figure cited in March 2026 to as high as $84.5 billion in late April 2026 [3, 6].
However, prediction markets focused on the IPO timeline have been more cautious. In March 2026, the probability of a 2026 IPO on one market reportedly fell from 46% to 19%, reflecting concerns over valuation and potential regulatory hurdles for defense contracts [5].
Why it matters for the IPO
Securing a role in another billion-dollar-plus contract directly strengthens the bull case for an eventual Anduril IPO by enhancing revenue visibility and helping to justify its soaring private market valuation. A deep and growing backlog of government contracts is a critical metric for public market investors in the defense sector, as it signals durable, long-term demand.
The company’s revenue has grown at a blistering pace, reportedly doubling to approximately $1 billion in 2024 and reaching a reported $2 billion in 2025 [1, 7]. The Space Force award supports projections that this trajectory can continue, a key requirement for commanding a premium valuation. Anduril’s last official funding round in June 2025 valued the company at $30.5 billion, or about 30 times its estimated 2024 revenue [1]. More recent secondary market activity and a rumored new funding round at a near-$60 billion valuation suggest that private investors are pricing in flawless execution on its many large-scale programs [2, 3].
Still, significant risks could complicate the IPO path. The company is not believed to be profitable and does not publish audited financials [1, 4, 8]. Some of its systems have faced setbacks in combat environments, and scaling manufacturing from a startup to the level of a defense prime is a significant operational challenge [1, 2]. While founder Palmer Luckey has stated an IPO will "definitely" happen, the timeline remains ambiguous, with estimates ranging from late 2026 to 2027 [1, 3, 4].
What changes the market next
Several key catalysts will determine the timing and valuation of Anduril's potential market debut. The most immediate is a rumored $4 billion funding round, which reports in early 2026 suggested could value the company at nearly double its last official $30.5 billion mark [2, 7]. The successful closing of this round would signal strong private investor confidence, while any delay or downward revision in terms could signal a cooling of sentiment.
Beyond funding, the outcome of the Air Force’s CCA program in fiscal 2026 represents a critical binary event. A production contract win against competitor General Atomics would be a transformative validation of Anduril’s model, while a loss would be a significant setback [1].
Finally, the public market's appetite for defense technology will be a major factor. The successful IPO of AEVEX Corp. (NYSE: AVEX), an unmanned systems provider, in April 2026 demonstrates that a path to public markets exists for the sector [9]. The performance of AEVEX and other public defense tech peers will help establish valuation benchmarks. The ultimate trigger, however, remains the company’s filing of a Form S-1 with the SEC, which would provide the first official look at its financials and make the prospect of an IPO concrete.
